Company

Year Founded

Inventors

Technology

ChemoGLO

ChemGLO provides products and services to assess occupational exposure to chemotherapy agents.

Arcato Labs

Arcato was founded by faculty member Mike Jay based on technology he developed at the University of Kentucky.  The company’s lead product is OraWax, a patented product that has an over-the-counter anesthetic (benzocaine) incorporated into its matrix so as to provide sustained release over a period of several hours.

NeuroGate

2011

Hal Kohn

NeuroGate is focused on developing a new series of potent neurological agents to treat neuropathic pain and epilepsy.

Capture Pharmaceuticals

2010

Russ Mumper, Michael Jay

Capture is focused on developing oral and topical formulation of DPTA prodrugs as radionuclide decorporation agents.

Qualiber

2010

Leaf Huang

Qualiber is developing a drug-delivery system based on Huang’s nanoparticle that contains a drug stored within a core of calcium phosphate, the same material that makes up bone. When the particle is engulfed by a cancer cell, pockets of acidity within the cell dissolve the core and release the drug. READ MORE

Synereca

2009

Scott Singleton

The company aims to address the growing problem of bacterial resistance to current antibiotics by developing orally active drugs that support existing antibiotics by inhibiting the RecA, a critical enzyme in bacterial reproduction and mutation that result in resistance to antibiotics. READ MORE

NovoLipid

2009

Moo Cho, Michael Hackett

NovoLipid, Inc. is a small molecule oncology drug discovery and development company built on a unique and proprietary drug modification platform. READ MORE

Qualyst Transporter Solutions

2003

Kim Brouwer, Gary Pollack, Dhiren Thakker

Qualyst's focus is commercializing novel and proprietary ADMET (absorption, distribution, metabolism, excretion, and toxicity) technologies for drug discovery and development, predominantly through non-exclusive out-licensing and fee-for-service offerings. READ MORE

Asklepios BioPharmaceutical Inc.

The company is engaged in the development and delivery of novel protein and cellular based therapies through design of proprietary Biological Nano ParticlesTM ("BNP"). READ MORE

Oriel Therapeutics (acquired by Sandoz)

Anthony Hickey, Timothy Crowder

Acquired by Sandoz in 2010

Cirrus Pharmaceuticals, Inc.

Cirrus is a contract product development company that assists biotechnology and pharmaceutical companies with formulation development and regulated testing of pharmaceutical products throughout their development. READ MORE